RxDoctor Payments Data

James Sweet

Anesthesiology · Oklahoma City, OKNPI 1851778591

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Stryker at 31.1% of the total. Reporting peaked in 2022 at $1,610 and has fallen 81.2% since, to $302 in 2025. Among anesthesiology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,177in general payments, 2019–2025

Across 54 payments — averaging $77.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Boston Scientific$849
  • Relievant Medsystems, Inc.$601
  • Nevro Corp.$576
  • Abbott$374
  • AbbVie$166
  • plus $312 from 8 others

What the payments were for

  • Travel & lodging$1,70041%
  • Food & beverage$2,47759%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,177 in reported general payments places this provider in the 95th percentile of 476 anesthesiology providers in Oklahoma.

See all anesthesiology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$231,647
Medicare patients
435
Services billed
1,974

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen2,751$96,370
Xtampza ErOxycodone Myristate32$13,112
OxycontinOxycodone Hcl21$12,512
Fentanyl116$12,041
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen363$10,702
Gabapentin620$7,802
Pregabalin405$7,731
Morphine Sulfate ErMorphine Sulfate235$7,654
Acetaminophen-CodeineAcetaminophen With Codeine152$4,877
Tizanidine Hcl296$4,846
Oxycodone Hcl242$4,626
Methocarbamol237$3,428
Duloxetine Hcl237$3,256
Buprenorphine20$3,244
Morphine Sulfate93$3,099

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →